Publications - RTI Health Solutions

Publications

Full Publications List (1537 results)

Search Publications

Displaying 61 through 80 of 1537 items.

« Previous Page 1 2 3 4 5 6 7 8 9 10 20 30 40 50 60 70 77 Next » [Show All]

2013

Johnson, F.R., E. Lancsar, D. Marshall, V. Kilambi, A. Muhlbacher, D.A. Regier, B.W. Bresnahan, B. Kanninen, and J.F. Bridges. (2013). "Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force." Value in Health, 16(1):3-13.

Stated-preference methods are a class of evaluation techniques for studying the preferences of patients and other stakeholders. While these methods span a variety of techniques, conjoint-analysis... Full Abstract »

Spinner, D.S., J. Birt, J.W. Walter, L. Bowman, J. Mauskopf, M.F. Drummond, and C. Copley-Merriman. (2013). "Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions." ClinicoEconomics and Outcomes Research, 5:69-85.

Background: Health-technology assessment (HTA) plays an important role in informing drug-reimbursement decision-making in many countries. HTA processes for the Pharmaceutical Benefits Advisory... Full Abstract »

Ozdemir, S., and F.R. Johnson. (2013). "Estimating willingness to pay: Do health and environmental researchers have different methodological standards?." Applied Economics, 45(16):2215-2229.

Health and environmental economists have been employing Stated-Preference (SP) methods such as conjoint analysis or contingent valuation to estimate the monetary value of public health interventions... Full Abstract »

Stull, D.E., and K. Houghton. (2013). "Identifying differential responders and their characteristics in clinical trials: Innovative methods for analyzing longitudinal data." Value in Health, 16(1):164-176.

Objectives To present a step-by-step example of the examination of heterogeneity within clinical trial data by using a growth mixture modeling (GMM) approach. Methods Secondary data from a... Full Abstract »

Brubaker, L., H.E. Richter, M.D. Barber, Y. Hsu, D.D. Rahn, S. Menefee, A. Visco, C. Spino, S. Martin, and S.F. Meikle. (2013). "Pelvic floor disorders clinical trials: participant recruitment and retention." International Urogynecology Journal, 24(1):73-79.

Introduction and hypothesis We used a focus-group methodology to gather information about women’s knowledge and attitudes regarding research participation. Methods Two in-person focus groups at... Full Abstract »

Mauskopf, J., C. Chirila, C. Masaquel, K.S. Boye, L. Bowman, J. Birt, and D. Grainger. (2013). "Relationship between financial impact and coverage of drugs in Australia." International Journal of Technology Assessment in Health Care, 29(1):92-100.

Objectives: The aim of this study was to estimate the relationship between the financial impact of a new drug and the recommendation for reimbursement by the Australian Pharmaceutical Benefits... Full Abstract »

Henk, H.J., J.A. Kaye, K.J. Rothman, L.K. Becker, J.C. Legg, and X. Li. (2013). "Variation by age in neutropenic complications among patients with cancer receiving chemotherapy." Community Oncology, 10(1):16-26.

Background Age is among the most important risk factors for neutropenia-related hospitalization, but evidence is limited regarding the relative contributions of age and other risk factors.... Full Abstract »

2012

Antonova, E.N., C.E. Rycroft, C.S. Ambrose, T. Heikkinen, and N. Principi. (2012). "Burden of paediatric influenza in Western Europe: A systematic review." Biomed Central Public Health, 12:968-.

Background Influenza illness in children causes significant clinical and economic burden. Although some European countries have adopted influenza immunisation policies for healthy children, the... Full Abstract »

Braun, L., V. Sood, S. Hogue, B. Lieberman, and C. Copley-Merriman. (2012). "High burden and unmet patient needs in chronic kidney disease." International Journal of Nephrology and Renovascular Disease, 5:151-163.

Chronic kidney disease (CKD) is a complex debilitating condition affecting more than 70 million people worldwide. With the increased prevalence in risk factors such as diabetes, hypertension, and... Full Abstract »

Castellsague, J., N. Riera-Guardia, B. Calingaert, C. Varas-Lorenzo, A. Fourrier-Reglat, F. Nicotra, M. Sturkenboom, and S. Perez-Gutthann. (2012). "Individual NSAIDs and Upper Gastrointestinal Complications: A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project)." Drug Safety, 35(12):1127-1146.

Background: The risk of upper gastrointestinal (GI) complications associated with the use of NSAIDs is a serious public health concern. The risk varies between individual NSAIDs; however, there is... Full Abstract »

Mohamed, A.F., V. Kilambi , M.P. Luo, R.G. Iyer, and J.M. Li-McLeod. (2012). "Patient and parent preferences for immunoglobulin treatments: A conjoint analysis." Journal of Medical Economics, 15(6):1183-1191.

Objectives: The purpose was to quantify patient and parent preferences for administration attributes of immunoglobulin (IG) treatments; and determine which administration attributes were most... Full Abstract »

Wong, M.K., A.F. Mohamed, A.B. Hauber, J.C. Yang, Z. Liu, J. Rogerio, and C.A. Garay. (2012). "Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma." Journal of Medical Economics, 15(6):1139-1148.

Background: The aims of this study were to quantify and contrast patient preferences between second-line advanced renal cell carcinoma (RCC) medication profiles and their associated benefits and... Full Abstract »

Kauf, T.L., A.F. Mohamed, A.B. Hauber, D. Fetzer, and A. Ahmad. (2012). "Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection." Patient: Patient-Centered Outcomes Research, 5(4):265-278.

Background: Some patients with chronic hepatitis C virus (HCV) infection forego treatment due to concerns about treatment efficacy, treatment duration, and side effects. Objective: The purpose of... Full Abstract »

Andrews, E.B., A.W. Gilsenan, K. Midkiff, B. Sherrill, Y. Wu, B.H. Mann, and D. Masica. (2012). "The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years." J Bone Miner Res , 27(12):2429-2437.

The Osteosarcoma Surveillance Study, an ongoing 15-year surveillance study initiated in 2003, is a postmarketing commitment to the United States (US) Food and Drug Administration to evaluate a... Full Abstract »

Schneeweiss, S., J.A. Rassen, R.J. Glynn, J. Myers, G.W. Daniel, J. Singer, D.H. Solomon, S.Y. Kim, K.J. Rothman, and J. Avorn. (2012). "Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments." BMC Medical Research Methodology, 12(11):180-.

Background Adjusting for laboratory test results may result in better confounding control when added to administrative claims data in the study of treatment effects. However, missing values can... Full Abstract »

Barrett, A., M. Clark, C. DeMuro, and D. Esser. (2012). "Proxy-reported questionnaires for young children with asthma: A structured review." European Respiratory Journal, Epub ahead of print.

Which proxy-reported outcome measures have been developed for use with children aged 6 years and younger to assess asthma symptoms, asthma control, and asthma-specific health-related quality of... Full Abstract »

Zarkin, G.A., A.J. Cowell, K.A. Hicks, M.J. Mills, S. Belenko, L.J. Dunlap, and V. Keyes. (2012). "Lifetime benefits and costs of diverting substance-abusing offenders from state prison." Crime and Delinquency, Epub ahead of print.

Prisons hold a disproportionate number of society’s drug abusers. Approximately 50% of state prisoners meet the criteria for a diagnosis of drug abuse or dependence; however, only 10% of prisoners... Full Abstract »

Bailey, D.B., M. Raspa, E. Bishop, D. Mitra, A. Wheeler, and P. Sacco. (2012). "Health and economic consequences of Fragile X syndrome for caregivers." Journal of Developmental and Behavioral Pediatrics, 33(9):705-712.

OBJECTIVE: : To describe the health and economic burden experienced by caregivers of individuals with fragile X syndrome (FXS) and test the assumption that burden is associated with specific... Full Abstract »

Karve, S.J., J.M. Panish, R.G. Dirani, and S.D. Candrilli. (2012). "Health care utilization and costs among Medicaid-enrolled patients with schizophrenia experiencing multiple psychiatric relapses." Health Outcomes Research in Medicine, 3(4):e183-e194.

Objective This study compared all-cause and schizophrenia-related health care utilization and costs among patients with schizophrenia using second-generation oral antipsychotics (SGOAs) and... Full Abstract »

Margulis, A.V., A.A. Mitchell, S.M. Gilboa , M.M. Werler, M.A. Mittleman, R.J. Glynn, and S. Hernandez-Diaz. (2012). "Use of topiramate in pregnancy and risk of oral clefts." American Journal of Obstetrics and Gynecology, 207(5):405.e1-405e.7.

Objective The objective of this study was to evaluate the association between the use of monotherapy topiramate in pregnancy and cleft lip with or without cleft palate (CL/P) in the offspring.... Full Abstract »

Displaying 61 through 80 of 1537 items.

« Previous Page 1 2 3 4 5 6 7 8 9 10 20 30 40 50 60 70 77 Next » [Show All]